MONOLISA Anti-HAV IgM EIA

Image
bvd_72495_pdp.jpg

Overview

An enzyme immunoassay for the in vitro detection of IgM antibodies to hepatitis A virus (HAV) in human adult and pediatric serum or plasma
Read full description Ordering Information

Description

Description

MONOLISA Anti-HAV IgM EIA is for the detection of IgM antibodies to hepatitis A virus (HAV) in human (adult or pediatric) serum or plasma. Specific IgM antibodies to HAV (anti-HAV IgM) appear a few days after infection, reach a peak rapidly, and persist at elevated levels in the bloodstream for about two months, before declining during late convalescence. The recent availability of anti-HAV vaccines has prompted the development of more sensitive assays, used for screening unvaccinated individuals, to follow up on antibody response after vaccination, and to estimate the need and timing of booster vaccinations. Specificity in hepatitis testing is critical—trust Bio-Rad’s expertise in immunology and continually updated reagents for all hepatitis testing needs.

Ordering

Ordering

items

Use the filters below to refine results!

Documents

Documents

Number Description Options
P-130
Hepatitis Product Brochure (U.S. Version)
[ Add to Cart (Free) ]